1009735-22-1 Usage
Description
Methy 2,6-dibromopyridine-3-carboxylate is a chemical compound with the molecular formula C7H5Br2NO2. It is a derivative of pyridine, containing two bromine atoms and a methyl ester group. Methy 2,6-dibromopyridine-3-carboxylate is known for its unique structure and reactivity, making it a valuable compound with a wide range of potential applications in the chemical industry.
Uses
Used in Pharmaceutical Synthesis:
Methy 2,6-dibromopyridine-3-carboxylate is used as an intermediate in the synthesis of pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicine.
Used in Agrochemical Production:
In the agrochemical industry, Methy 2,6-dibromopyridine-3-carboxylate is utilized as an intermediate for the production of various agrochemicals. Its properties make it suitable for creating effective solutions for agricultural applications.
Used as a Building Block in Organic Chemistry:
Methy 2,6-dibromopyridine-3-carboxylate also serves as a building block in organic chemistry, enabling the creation of more complex molecules. Its reactivity and structural features make it an essential component in the synthesis of advanced organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1009735-22-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,7,3 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1009735-22:
(9*1)+(8*0)+(7*0)+(6*9)+(5*7)+(4*3)+(3*5)+(2*2)+(1*2)=131
131 % 10 = 1
So 1009735-22-1 is a valid CAS Registry Number.
1009735-22-1Relevant articles and documents
BENZO[B][1,8]NAPHTHYRIDINE ACETIC ACID DERIVATIVES AND METHODS OF USE
-
Page/Page column 130, (2020/12/01)
Compounds of Formula I or pharmaceutically acceptable salts or esters thereof capable of binding to and modulating the activity of a stimulator of interferon genes (STING) protein are provided. Methods involving compounds of Formula I as effective modulators of STING are also provided.
